Get started
Author

David Cassie

Observed names: David M Cassie, Mr Dave Cassie
ORCID: 0000-0002-5360-7768
Observed ORCID: 0000-0002-5360-7768
OpenAlex ID: A5077238389
Update on CVD 103-HgR single-dose, live oral cholera vaccine
2021 · James McCarty, Lisa Bedell, et al. · Expert Review of Vaccines · 16
Long-Term Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Adolescents Aged 12–17 Years in the United States
2021 · James M. McCarty, David Cassie, et al. · American Journal of Tropical Medicine and Hygiene · 16
PDF
Brincidofovir in the Era of Mpox
2025 · James McCarty, David Cassie, et al. · Expert Review of Anti-infective Therapy · 11
Safety and Immunogenicity of Live Oral Cholera Vaccine CVD 103-HgR in Children Aged 2–5 Years in the United States
2020 · James M. McCarty, David Cassie, et al. · American Journal of Tropical Medicine and Hygiene · 10
PDF
Compatible co-administration of BioThrax® vaccine and ciprofloxacin—Results of a randomized open-label drug-vaccine interaction trial
2024 · David Cassie, Janice Longstreth, et al. · Vaccine X · 2
A phase 4, open-label, single arm, multi-center study to evaluate the safety of a smallpox vaccine in previously vaccinated individuals
2026 · David Cassie, Vanja Komlenovic, et al. · Vaccine · 1
ACAM2000 vaccine safety and immunogenicity considerations for smallpox and mpox
2026 · Vanja Komlenovic, James McCarty, et al. · Expert Review of Vaccines
A Phase 1, Open‐Label, Randomized Study to Investigate the Pharmacokinetics and Safety of Multiple Doses of Intranasal Naloxone in Healthy Participants
2026 · David Cassie, Bob Warnock, et al. · Clinical and Translational Science
A phase 1, first-in-human, open label, single ascending dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of stabilized isoamyl nitrite nasal spray in healthy adult participants
2025 · David Cassie, Mila Mirceta, et al. · Journal of Pharmacology and Experimental Therapeutics
A Healthy Participant Study to Evaluate the Bioequivalence of Form H and Form II Tablets of the Smallpox Antiviral Brincidofovir (BCV)
2025 · Mr Dave Cassie, Mrs Vanja Komlenovic, et al. · International Journal of Infectious Diseases
PDF
A Healthy Participant Study to Evaluate the Bioequivalence of Form H and Form II Tablets of the Smallpox Antiviral Brincidofovir
2025 · David M Cassie, Vanja Komlenovic, et al. · ASEAN Journal of Psychiatry
Immunogenicity of partial doses of live oral cholera vaccine CVD 103-HgR in children in the United States
2023 · James M. McCarty, David Cassie, et al. · Vaccine
Works count: 12
Citation count: 56
H-index: 4
I10-index: 4
Year
Topic
Type